Women’s Health Innovation: Rejoni won FDA approval for the Juveena Hydrogel System to reduce intrauterine adhesions after hysteroscopic adhesiolysis, a step aimed at lowering repeat procedures and improving fertility outcomes. Cardio Diagnostics Expansion: Elucid named Mark Miller as Chief Revenue Officer ahead of its cardiovascular platform launch, pairing Plaque-IQ with BioIntegrated FFR-CT (pending clearance) to support precision heart disease diagnosis. Rare Disease Drug Development: Tectonic Therapeutic reported favorable Phase 1a results for TX2100 in hereditary hemorrhagic telangiectasia and said the FDA granted Fast Track status. Cancer Care Precision: Veracyte highlighted Decipher Prostate Genomic Classifier findings showing who may benefit from adding short-term hormone therapy to dose-escalated radiation in intermediate-risk prostate cancer. Mental Health & Care Navigation: Bristol Myers Squibb funded a $229,337 pilot by the National Shattering Silence Coalition to deploy family navigators during severe mental illness crises. Massachusetts Court Watch: Lindsay Clancy returns to Plymouth Superior Court for a hearing that could shape whether her triple-murder case proceeds to retrial after a mistrial tied to a holdout juror. Public Health Tech in Boston: Boston partnered with Basis Research Institute to use AI to “listen” to rat communication and better target disease-carrying rodent hotspots.